In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.

The in vitro activities of ravuconazole and voriconazole were compared with those of amphotericin B, flucytosine (5FC), itraconazole, and fluconazole against 6,970 isolates of Candida spp. obtained from over 200 medical centers worldwide. Both ravuconazole and voriconazole were very active against a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pfaller, M. A., Messer, S. A., Hollis, R. J., Jones, R. N., Diekema, D. J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2002
Materias:
Susceptibility
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC127275/
https://ncbi.nlm.nih.gov/pubmed/12019081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1723-1727.2002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares